UY34666A - Inhibidores de quinasa a base de ariléter - Google Patents
Inhibidores de quinasa a base de ariléterInfo
- Publication number
- UY34666A UY34666A UY0001034666A UY34666A UY34666A UY 34666 A UY34666 A UY 34666A UY 0001034666 A UY0001034666 A UY 0001034666A UY 34666 A UY34666 A UY 34666A UY 34666 A UY34666 A UY 34666A
- Authority
- UY
- Uruguay
- Prior art keywords
- ariléter
- kinase inhibitors
- based kinase
- inhibitors
- página
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente descripción se refiere en general a compuestos que pueden inhibir la AAK1 (quinasa asoc iada con el adaptador 1), composiciones que comprenden tales compuestos y métodos para inhibir la A AK1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261608737P | 2012-03-09 | 2012-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34666A true UY34666A (es) | 2013-09-30 |
Family
ID=47892007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034666A UY34666A (es) | 2012-03-09 | 2013-03-08 | Inhibidores de quinasa a base de ariléter |
Country Status (11)
Country | Link |
---|---|
US (2) | US8703953B2 (es) |
EP (1) | EP2822952B1 (es) |
JP (1) | JP2015510881A (es) |
CN (1) | CN104144932A (es) |
AR (1) | AR090293A1 (es) |
CA (1) | CA2866671A1 (es) |
EA (1) | EA201491647A1 (es) |
MX (1) | MX2014010684A (es) |
TW (1) | TW201341387A (es) |
UY (1) | UY34666A (es) |
WO (1) | WO2013134036A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8901305B2 (en) | 2012-07-31 | 2014-12-02 | Bristol-Myers Squibb Company | Aryl lactam kinase inhibitors |
WO2014130258A1 (en) | 2013-02-22 | 2014-08-28 | Bristol-Myers Squibb Company | 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1) |
JP6522602B2 (ja) | 2013-07-02 | 2019-05-29 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Rock阻害剤としての三環式ピリド−カルボキサミド誘導体 |
CN105492444B (zh) | 2013-07-02 | 2018-09-07 | 百时美施贵宝公司 | 作为rock抑制剂的三环吡啶-甲酰胺衍生物 |
EP3019475A1 (en) | 2013-07-08 | 2016-05-18 | Bristol-Myers Squibb Company | Aryl amide kinase inhibitors |
WO2015038112A1 (en) * | 2013-09-11 | 2015-03-19 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
ES2678877T3 (es) | 2013-10-11 | 2018-08-20 | Bristol-Myers Squibb Company | Inhibidores de pirrolotriazina quinasa |
ES2693771T3 (es) * | 2014-01-29 | 2018-12-13 | Bristol-Myers Squibb Company | Inhibidores de aril lactama quinasa |
ES2701903T3 (es) * | 2014-01-31 | 2019-02-26 | Bristol Myers Squibb Co | Inhibidores de cinasa a base de quinolina |
PL3126351T3 (pl) | 2014-04-02 | 2019-03-29 | Bristol-Myers Squibb Company | Biarylowe inhibitory kinazy |
ES2740224T3 (es) * | 2015-04-10 | 2020-02-05 | Bristol Myers Squibb Co | 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1) |
KR20180011050A (ko) * | 2015-05-22 | 2018-01-31 | 다우 아그로사이언시즈 엘엘씨 | 스즈키 커플링 후 팔라듐 촉매의 회수 및/또는 재사용 |
EP3356330B1 (en) * | 2015-10-01 | 2019-11-20 | Bristol-Myers Squibb Company | Biaryl kinase inhibitors |
CN108368084B (zh) * | 2015-10-01 | 2020-10-16 | 百时美施贵宝公司 | 联芳基激酶抑制剂 |
HRP20211553T1 (hr) | 2016-12-15 | 2021-12-24 | F. Hoffmann - La Roche Ag | Postupak za pripravu inhibitora btk |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9307570A (pt) | 1992-12-02 | 1999-05-25 | Pfizer | Diéteres de catecol como inibidores seletivos de pdeiv |
US5709861A (en) | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
US20070060606A1 (en) * | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
ES2301793T3 (es) | 2002-04-05 | 2008-07-01 | Boehringer Ingelheim Pharmaceuticals Inc. | Cianamidas utiles como inhibidores reversibles de cisteina proteasas. |
WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
EP1593667A4 (en) | 2003-02-12 | 2009-03-04 | Takeda Pharmaceutical | AMINE DERIVATIVE |
WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
US20050288338A1 (en) | 2004-06-24 | 2005-12-29 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
CN100494167C (zh) | 2005-08-02 | 2009-06-03 | 天津大学 | 抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用 |
JP2007217408A (ja) | 2006-01-19 | 2007-08-30 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
CA2869945C (en) | 2006-04-07 | 2018-01-23 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
WO2008022154A2 (en) | 2006-08-14 | 2008-02-21 | Wyeth | Methods of identifying agents for treating neurological disorders |
JP2010530217A (ja) * | 2007-05-29 | 2010-09-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 造骨活性及び破骨活性の調節に関与する分子、並びにその使用法 |
DE102007025717A1 (de) * | 2007-06-01 | 2008-12-11 | Merck Patent Gmbh | Arylether-pyridazinonderivate |
US8497271B2 (en) | 2009-10-07 | 2013-07-30 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
-
2013
- 2013-02-26 US US13/777,144 patent/US8703953B2/en active Active
- 2013-02-28 MX MX2014010684A patent/MX2014010684A/es unknown
- 2013-02-28 EP EP13710203.4A patent/EP2822952B1/en active Active
- 2013-02-28 CA CA2866671A patent/CA2866671A1/en not_active Abandoned
- 2013-02-28 CN CN201380012323.6A patent/CN104144932A/zh active Pending
- 2013-02-28 EA EA201491647A patent/EA201491647A1/ru unknown
- 2013-02-28 WO PCT/US2013/028230 patent/WO2013134036A1/en active Application Filing
- 2013-02-28 JP JP2014560950A patent/JP2015510881A/ja not_active Withdrawn
- 2013-03-08 UY UY0001034666A patent/UY34666A/es unknown
- 2013-03-08 TW TW102108352A patent/TW201341387A/zh unknown
- 2013-03-11 AR ARP130100766A patent/AR090293A1/es unknown
-
2014
- 2014-02-24 US US14/188,141 patent/US8969564B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2866671A1 (en) | 2013-09-12 |
MX2014010684A (es) | 2014-10-17 |
AR090293A1 (es) | 2014-11-05 |
CN104144932A (zh) | 2014-11-12 |
JP2015510881A (ja) | 2015-04-13 |
US8969564B2 (en) | 2015-03-03 |
EP2822952B1 (en) | 2016-04-06 |
EA201491647A1 (ru) | 2014-12-30 |
EP2822952A1 (en) | 2015-01-14 |
US20140179725A1 (en) | 2014-06-26 |
WO2013134036A1 (en) | 2013-09-12 |
US8703953B2 (en) | 2014-04-22 |
TW201341387A (zh) | 2013-10-16 |
US20130237555A1 (en) | 2013-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34666A (es) | Inhibidores de quinasa a base de ariléter | |
UY4276Q (es) | Controlador para dispositivo electrónico | |
UY4211Q (es) | Pizarra para marcadores | |
UY34654A (es) | Inhibidores de la beta-secretasa | |
UY4169Q (es) | Altoparlante | |
UY33958A (es) | Inhibidores de la glucosilceramida sintasa | |
UY34817A (es) | Tienopirimidinas | |
UY34027A (es) | Inhibidores sustituidos de acetil-coa carboxilasa. | |
UY33930A (es) | Inhibidores novedosos de quinasas | |
UY4281Q (es) | Juguera | |
UY34818A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
UY4210Q (es) | Silla | |
UY4223Q (es) | Banco | |
BR112015003294A2 (pt) | caldeira de armazenamento | |
UY4153Q (es) | Batería | |
UY4181Q (es) | Taza | |
UY34677A (es) | Imidazopiridazinas sustituidas | |
UY4152Q (es) | Batería | |
UY4237Q (es) | Taburete | |
UY34518A (es) | Composiciones que contienen inhibidores de quinasas | |
UY34033A (es) | ?nuevos inhibidores de quinasa?. | |
TN2011000372A1 (fr) | جهاز مراقبة وتحكم في استهلاك المياه | |
CL2012003246S1 (es) | Escritorio electrónico. | |
UY4256Q (es) | ?motocicleta?. | |
TN2011000162A1 (fr) | نظام هندسي ومعماري مبتكر لانشاء البناء عامة ومواكب للتكنولوجيات المتطورة مادته الاساسية الطين والتربة |